Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Integration of Wearable Sensor Devices Into a Single System to Predict the Onset of Sepsis

NCT: NCT07595848 · NOT_YET_RECRUITING

NCT IDNCT07595848
StatusNOT_YET_RECRUITING
Completion2027-03-01
SponsorCheck Point R & D Ltd (INDUSTRY)
First posted
Last updated

Brief Summary

The purpose of this clinical investigation is to evaluate the integration of data from the CPC12S telemonitoring device, the CPC temperature/humidity sensor, and the IDRO sweat lactate sensor into a single system for the prediction of sepsis onset in ICU patients at risk of developing sepsis. Patients will be monitored for up to 48 hours, and the collected physiological and biomarker data will be used to support the development of artificial intelligence and machine learning models for sepsis prediction.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑